Skip to main content
OpenTrials

Clinical trial condition

GastroEsophageal Cancer

Explore clinical trials studying GastroEsophageal Cancer. Study availability and eligibility vary by location and protocol.

62 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

GastroEsophageal Cancer trial results

Completed

An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients

NCT04099641

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
  • Cleveland Clinic Florida - Weston Weston, Florida, United States
  • Columbus Regional Research Institute Columbus, Georgia, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer

NCT02317991

Conditions
GastroEsophageal Cancer
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Florida Cancer Specialists-South Fort Myers, Florida, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Florida Cancer Specialists-North St. Petersburg, Florida, United States
View Trial Details
Completed

Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma

NCT03409848

Conditions
Adenocarcinoma Gastric, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • Gesundheitszentrum St. Marien Amberg - MVZ Amberg, Germany
  • Gesundheitszentrum Wetterau - Facharztzentrum Bad Nauheim, Germany
  • Helios Klinikum Bad Saarow - Hämatologie, Onkologie und Palliativmedizin Bad Saarow, Germany
  • Charité Universitätsmedizin Campus Virchow Klinikum - Hämatologie / Onkologie Berlin, Germany
View all 35 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

NCT02586987

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +38 more
Locations
  • Research Site Chicago, Illinois, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Las Vegas, Nevada, United States
  • Research Site New Brunswick, New Jersey, United States
View Trial Details
Completed

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

NCT01611857

Conditions
GastroEsophageal Cancer, Malignant Solid Tumour
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists-South Fort Myers, Florida, United States
  • Florida Cancer Specialists-Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists-North St. Petersburg, Florida, United States
View Trial Details
Completed

Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT

NCT00718354

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Mahatma Gandhi Cancer Hospital & Research Institute ,1/7 M.V.P. Colony, - ,, . Vishakhapattanam, Andhra Pradesh, India
  • Mahavir Cancer Sansthan,Phulwari Sharif Patna, Bihar, India
  • Gujarat Cancer Research Institute, Civil Hospital Campus,Asarwa, , Ahmedabad, Gujarat, India
  • Department Of Radiotherapy,S.S.G. Hospital, - Baroda,Vadodara, Gujarat, India
View all 15 locations
View Trial Details

Related conditions